Quality Assessment of the Chinese Clinical Trial Protocols Regarding Treatments for Coronavirus Disease 2019.
Saved in:
| Title: | Quality Assessment of the Chinese Clinical Trial Protocols Regarding Treatments for Coronavirus Disease 2019. |
|---|---|
| Authors: | Zhang J; Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China., Lu Y; Department of Pharmacy, The Third People's Hospital of Chengdu, Chengdu, China., Kwong JS; Global Health Nursing, Graduate School of Nursing Science, St. Luke's International University, Tokyo, Japan., Li X; Department of Pharmacy, Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region, Chengdu, China., Zheng W; Experimental Cancer Medicine, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.; Clinical Research Center and Center of Allogeneic Stem Cell Transplantation(CAST), Karolinska University Hospital Huddinge, Stockholm, Sweden., He R; Experimental Cancer Medicine, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden.; Clinical Research Center and Center of Allogeneic Stem Cell Transplantation(CAST), Karolinska University Hospital Huddinge, Stockholm, Sweden. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2020 Aug 27; Vol. 11, pp. 1330. Date of Electronic Publication: 2020 Aug 27 (Print Publication: 2020). |
| Publication Type: | Systematic Review; Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2020.01330 |
